Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum

NCT00580073 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Loss of funding

Conditions

Rectal Cancer

Interventions

DRUG: FOLFOX4
DRUG: Cetuximab

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]
[object Object]
[object Object]